Literature DB >> 25850552

Intermediate-stage HCC--upfront resection can be feasible.

Alejandro Forner1, Marine Gilabert2, Jordi Bruix1, Jean-Luc Raoul2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25850552     DOI： 10.1038/nrclinonc.2014.122-c4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

1.  Intermediate-stage HCC--upfront resection can be feasible.

Authors:  Jian-Hong Zhong; Shi-Dong Lu; Yan-Yan Wang; Liang Ma; Le-Qun Li
Journal:  Nat Rev Clin Oncol       Date:  2015-04-07       Impact factor: 66.675

2.  Chemoembolization for intermediate HCC: is there proof of survival benefit?

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  J Hepatol       Date:  2011-10-17       Impact factor: 25.083

Review 3.  Prognosis prediction and staging.

Authors:  Alejandro Forner; Alvaro Díaz-González; Alexandre Liccioni; Ramón Vilana
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-08-23       Impact factor: 3.043

4.  Reply: Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

5.  The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011.

Authors:  Charles E Ray; Ziv J Haskal; Jean-Francois H Geschwind; Brian S Funaki
Journal:  J Vasc Interv Radiol       Date:  2011-10-27       Impact factor: 3.464

Review 6.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.

Authors:  Roberto S Oliveri; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

7.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 8.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675
  8 in total
  3 in total

1.  Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making.

Authors:  Yong-Fa Zhang; Jie Zhou; Wei Wei; Ru-Hai Zou; Min-Shan Chen; Wan Yee Lau; Ming Shi; Rong-Ping Guo
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

2.  Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.

Authors:  Yong-Fa Zhang; Ming Shi; Liang-He Lu; Lu Wang; Rong-Ping Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-04-19

3.  Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.

Authors:  Meng Li; Yongjie Xin; Sirui Fu; Zaiyi Liu; Yong Li; Baoshan Hu; Shuting Chen; Changhong Liang; Ligong Lu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.